GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, will present at the Bank of America Merrill Lynch 2013 Healthcare Conference to be held at Encore at the Wynn in Las Vegas on ...
GenMark Diagnostics, Inc. (NASDAQ:GNMK) today announced that it plans to release its first quarter earnings results after market close on Wednesday, May 8, 2013.
Genmark Diagnostics (NASDAQ:GNMK) will report earnings after markets close on Wednesday, May 8th. GenMark Diagnostics Inc. is a molecular diagnostics company focused on developing and commercializing its biomarker detection technology.
Company Name Last Price Change VI (1 is avg.) ABIOMED (ABMD) lifts 2.8% on weak volume US$18.46 50c [2.8%] 0.5 GenMark Diagnostics (GNMK) accelerates rise: up 3.1% in 2 days US$15.54 34c [2.2%] 0.8 AMAG Pharmaceuticals (AMAG) increases ...
Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. To see all exchange delays, please see disclaimer.